Generic drugs strategy

In spite of this reeord of sueeess, two of the provisions governing generie drug approval prior to patent expiration (the 180-day exelusivity and the 30-month stay provisions) are suseeptible to strategies that, in some cases, may have prevented the availability of more generic drugs. These provisions continue to have the potential for abuse. 

So if big new products were going to be sparse and the generic drug makers couldn t be blocked, the pharmaceutical industry turned to the other tried-and-true business strategy for pumping up the bottom line marketing. From time beyond memory, drug companies had wooed doctors with... 

One strategy to deal with the competition from cheap generic drugs is to promote the concept of brand rather than product. Branding was originally used to denote product purity by the early pharmaceutical companies, in much the same way as other industries did (e.g. soaps). The term Brand equity refers to the unique set of assets linked to the brand name, which adds value to the product and gives... 

Matheis, K., et al., A generic operational strategy to quahfy translational safety biomarkers. Drug Discov Today, 2011.16(13-14) p. 600-8. 

Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, HaU S, Joos T, Kraus S, Kretscbmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal J, Molac B (2011). A generic operational strategy to qualify translational safety biomarkers. Drug Discovery Today, 16(13) 600-608. 

---